Home NDC 71610-353-04 Tadalafil
Product NDC 71610-353
Requested package NDC 71610-353-04
11-digit product format 716100353
Labeler code 71610
Product ID 71610-353_b5ab073b-8449-4044-be5e-fc4aee8835c1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tadalafil
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Aphena Pharma Solutions - Tennessee, LLC
Application ANDA090141
Marketing category ANDA
Marketing start 2018-10-09
Marketing end 0000-00-00
Substance TADALAFIL
Active strength 20 mg/1
Pharmacologic classes Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090141-001 TADALAFIL TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 A090141-002 TADALAFIL TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 A090141-003 TADALAFIL TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 A090141-004 TADALAFIL TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A090141-001 TADALAFIL 2.5MG TABLET / ORAL AB1 2018-05-22 a50c72e98297…2026-08-01 22:54:32 2026-06 A090141-002 TADALAFIL 5MG TABLET / ORAL AB1 2018-05-22 a50c72e98297…2026-08-01 22:54:32 2026-06 A090141-003 TADALAFIL 10MG TABLET / ORAL AB1 2018-05-22 a50c72e98297…2026-08-01 22:54:32 2026-06 A090141-004 TADALAFIL 20MG TABLET / ORAL AB1 2018-05-22 a50c72e98297…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71610-353-04 Tadalafil 4 in 1 BOTTLE TABLET, FILM COATED 4 2 71610-353-06 Tadalafil 6 in 1 BOTTLE TABLET, FILM COATED 6 2 71610-353-12 Tadalafil 12 in 1 BOTTLE TABLET, FILM COATED 12 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71610-353 TADALAFIL TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 Legacy NDC, 3 package rows 20191126_93b97b99-1bca-4390-abad-d52712818065.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71610-353-04 71610035304 4 TABLET, FILM COATED in 1 BOTTLE (71610-353-04) 2019-10-18 0000-00-00 No No Current